SECOND TIME IN FIVE MONTHS ???

Pictured from to left to right, Siera Pryer, James Dyer, Jasen Webb, Mia Bindon, bottom left, Charles Benjamin, Clifford Buckley, Jessee Armstead Jr. and Darrly Richards

Counterfeit prescription drug ring in Baton Rouge area results in multiple arrests

http://www.nola.com/crime/baton-rouge/index.ssf/2015/05/counterfeit_prescription_drug.html

Baton Rouge police and DEA make arrests on prescription drug fraud

http://theadvocate.com/news/police/14227831-123/baton-rouge-police-and-dea-make-arrests-on-prescription-drug-fraud

Officials arrested eight people, including seven Baton Rouge residents, accused of using fake prescriptions to obtain $45,000 worth of pain medication.

The Drug Enforcement Administration Diversion Squad, with the help of multiple local police agencies, rounded up the people wanted on warrants for allegedly buying and possessing narcotics they collected using prescriptions made to look as if they came from Baton Rouge medical facilities, an East Baton Rouge Parish Sheriff’s Office news release says.

The group obtained about 810 dosage units of Hydrocodone and about 1,220 dosage units of Oxycodone in the last year, together estimated to have a street value of $45,000, the release says.

Authorities booked into East Baton Rouge Parish Prison Tuesday Mia Bindon, 36, 1314 N. 48th Street; Charles Benjamin, 46, 4260 Billops Street; Clifford Buckley, 55, 3436 Osceola Street and Darrly Richards, 51, 3324 Wenonah Street, all accused of obtaining a controlled dangerous substance and possession of a Schedule II drug. Bindon was booked on two counts and Richards on three.

Jesse Armstead Jr., 57, 1229 N. 37th Street, was also arrested Tuesday on one count of an attempt to obtain a controlled dangerous substance by fraud.

Officials also arrested in November Siera Pryer, 77655 Lee Street, Maringouin; James Dyer, 2829 Tecumseh; and Jasen Webb, 5145 Maple Dr., all on obtaining a controlled dangerous substance and possession of a Schedule II drug. Webb was booked on three counts.

Agencies involved in the round up include Iberville Sheriff’s Office, East Baton Rouge Parish Sheriff’s Office, Louisiana State Police, West Baton Rouge Sheriff’s Office, Ascension Parish Sheriff’s Office and Iberia Parish Sheriff’s Office.

More arrests are anticipated, the release says.

I guess that Joint Commission no longer considered “PAIN” the FIFTH VITAL SIGN ?

stevemailbox

A Nurse from  OHIO writes:
“As a nurse I have tried to make a stand. Patients aren’t in the ICU without cause. It is horrifying to watch a patient suffer on a ventilator because the pharmacy is watching everything. I chose to do the ethical thing and medicate. I stayed within the confines of the orders however because I medicate more than all the other nurses I’m being accused of diversion. I’ve proven twice by taking their test that I was not. Now I have to worry that they will accuse me of stealing and selling the drugs because I can’t give a dirty sample. It is a witch hunt. I hate what my profession has become and it disgusts me that more of us aren’t standing up. When I first became a nurse you had to give the patient all they wanted. That created this wave of junkies. The board of pharmacy is going to be responsible for the next wave but its going to be legitimate patients they are refusing to help now. I can tell you that if you are able to make big donations and build hospital wings you can get anything you want.”
 

A Nurse from  WI writes:
“A nurse for over 50 years, I have seen patients and friends suffer needlessly, and have experienced the denial of humane treatment myself. The current climate of over-control and witch hunts is very alarming.”

How the DEA invented “narco-terrorism”

Minnesota Marijuana Legalization Update

Minnesota Marijuana Legalization Update: Medical Pot Program Expands To Include Patients With Chronic Pain

http://www.ibtimes.com/minnesota-marijuana-legalization-update-medical-pot-program-expands-include-patients-2208401

Minnesota next summer will open its medical marijuana program to patients who experience chronic pain, state Department of Health Commissioner Ed Ehlinger said Wednesday, according to the Star Tribune. The decision could add thousands of patients to the state’s program, which has struggled with low enrollment and high prices since it was launched in July.

This change will make Minnesota the 19th state where people with intractable pain — pain that cannot otherwise be cured or treated — can legally use medical marijuana, the Associated Press reported. Of the states where medical marijuana is legal, just five do not include severe, chronic or intractable pain as a qualifying condition.

ADVERTISING
 
 
 
 
 

Ehlinger said in a statement that it was a “tough choice,” according to the AP. However, he said, “given the strong medical focus of Minnesota’s medical cannabis program and the compelling testimony of hundreds of Minnesotans, it became clear that the right and compassionate choice was to add intractable pain to the program’s list of qualifying conditions.”

Marijuana Legality by State | FindTheHome

Minnesota’s medical marijuana program, which had 760 people enrolled as of Sunday, is one of the most restrictive in the country. To be accepted, patients need a doctor or other caregiver to certify they have one of nine serious health conditions, such as cancer, epilepsy, muscular dystrophy or Crohn’s disease, the Star Tribune reported. The state sells cannabis only in liquid or pill form, according to the Star Tribune, and it must be purchased at one of eight dispensaries owned by two approved companies — Leafline Labs and Minnesota Medical Solutions.

While pain patients make up the majority of medical marijuana users in other states, Minnesota residents were divided on the issue. In the leadup to the decision, many citizens lobbied the state’s health department to expand the program, while an eight-member panel of health experts recommended against it, citing concerns about drug abuse and a lack of evidence for the efficacy of treating pain through medical marijuana.

The expansion is set to take effect Aug. 1, 2016, if lawmakers do not make changes to it this spring. However, both the Republican-controlled House and the Democratic-Farmer-Labor-led Senate would have to vote against the addition for it to fail.

Another point of view about MT’s medical licensing board travesty

Dear Friends of Mark Ibsen,

 

I am truly saddened over the deplorable situations in Montana and Washington. Dr. Ibsen was a most caring, competent physician. If the government didn’t approve of his practice, they could have gotten him special training and supervision. We simply can’t take care of worthy, suffering patients only with interventionalists, rehabbers, and mental counselling. We need medical doctors like Dr. Ibsen. I have long advocated that we need a certification system for family physicians and internists who will do medical pain management. These physicians need to be known to government and all other concerned parties.   To decimate a good man and doctor like Dr. Ibsen is simply wrong. It’s also wrong for states like Montana and Washington to deprive ill, suffering intractable pain patients of treatment so they will die of cardiac-adrenal failure.   The wrongness is now forcing patients to come to California for humanitarian, competent help. Pain patients and their families should know that the problem of under-treatment could be resolved within months if willing doctors could be certified and trained to do medical pain management.   The rush to have “guidelines” is pretty much a farce and designed to protect the financial interests of certain physicians, hospitals, and other interests who don’t do chronic pain medical management.

With Deep Sympathies and Prayers for My Friend, Mark Ibsen,

Forest Tennant M.D., Dr. P.H.
Contact Information:

Forest Tennant M.D., Dr. P.H.
Veract Intractable Pain Clinic
338 S. Glendora Ave.
West Covina, CA 91790-3043
Clinic Ph: 626-919-0064
Clinic Fax: 626-919-0065
Office Ph: 626-919-7476
Office Fax: 626-919-7497

Websites:
www.foresttennant.com
www.hormonesandpaincare.com

The making of a college drug informant

The making of a college drug informant

http://www.cbsnews.com/videos/confidential-informants-part-1/

http://www.cbsnews.com/videos/confidential-informants-part-2/

College students talk with Lesley Stahl about how they were pressured into becoming confidential informants.

Lesley Stahl reports on law enforcement’s controversial use of young confidential informants in the war on drugs, some of whose cases ended tragically.

 

 

US PAIN FOUNDATION ASKS PATIENTS; “WHAT SHOULD WE BE WORKING ON?

US PAIN FOUNDATION ASKS PATIENTS; “WHAT SHOULD WE BE WORKING ON?”

The nation’s leading consumer pain organization is asking pain patients about the issues facing them.

“We are going to use the results to help develop our best course of action and to prioritize which states we are going to work to make change,” said Paul Gileno, Founder/President of the US Pain Foundation.

To take the survey, click here.

Gileno said the main purpose of the survey is to help people realize that there are issues that affect the quality of life of people with pain.

“We want people to be aware that their stories matter and finally we want people to realize that together we can make change in each state for better quality of care and access to needed treatments and medications,” Gileno told the National Pain Report.

The U.S. Pain Foundation understands the challenges and struggles those with pain endure. An organization created by people with pain for people with pain, we recognize and validate the 100 million Americans who courageously battle pain every day.

“The biggest challenge as always is going to be validating that pain is real and not having access to needed treatments, therapies and medications,” said Gileno.

On its website, the U.S. Pain Foundation supports the 4 Core Beliefs from the National Pain Strategy which will be released early in 2016.

  1. Chronic pain is a real and complex disease that may exist by itself or be linked with other medical conditions.
  2. Chronic pain is both an under-recognized and under-resourced public health crisis with devastating personal and economic impact.
  3. Effective chronic pain care requires access to a wide range of treatment options, including biomedical, behavioral health and complementary treatment.
  4. Denying appropriate care to people with chronic pain is unethical and can lead to unnecessary suffering, depression, disability and even suicide.

The US Pain Foundation is a partner with the National Pain Report. To learn more about the US Pain Foundation, visit their website.

Pain management: Patient needs must come first

Pain management: Patient needs must come first

http://drugtopics.modernmedicine.com/drug-topics/news/pain-management-patient-needs-must-come-first?page=0,0

In 2015, pain continues to be a conundrum for patients, practitioners, pharmacists, caregivers, long-term facilities, and payers. Balanced pain management is a comprehensive approach to diagnosing, treating, and controlling pain. It can include physical therapy and rehabilitation, psychological counseling, social support and/or medications, plus interventional procedures depending on an individual’s needs. Yet, many of our patients are not getting the care and relief they deserve, whether they suffer from acute or chronic pain. Unfortunately, we know from surveys that an estimated 40% to 70% of patients with chronic pain are not receiving proper medical treatment.1 Those with acute pain may face similar circumstances.

There are many complex reasons why patients are not getting adequate pain relief. Three important considerations are: reduced access to medications perceived to have a high cost; safety concerns, including the abuse, misuse, and diversion of opioids; and limited access to integrated pain management, such as physical medicine and rehabilitation, complementary care, and psychosocial counseling.

For the more than 100 million who suffer from chronic pain and untold millions with acute pain, access to appropriate, individualized pain management and clinical care is critical.2,3 Equally important is the safe use of medications when they are prescribed.

As the population, especially the aging population, continues to grow, so will the national pain crisis. New strategies are needed to help improve access, outcomes, and medication safety.

Pain and the role of multimodal analgesia

One step in the right direction is to ensure hospitalized patients with acute pain have their pain resolved effectively and efficiently. If not treated effectively, acute pain can become chronic, and chronic pain patients use a substantial portion of healthcare resources.4,5

Opioids are commonly prescribed for acute pain in the hospital setting. Although these drugs play an important role in the treatment of pain and are inexpensive in generic form, they can be associated with serious adverse events such as respiratory depression and bowel obstruction, as well as other complications such as sedation and dizziness leading to workplace accidents and falls. Ironically, hospitals may be over-relying on the use of opioids alone versus other pain management strategies, significantly increasing patients’ risk for adverse events and considerably driving up total costs with readmissions, longer stays, and additional care. According to data from a 2013 published study, total hospital costs for certain surgical procedures in which an opioid-related adverse drug event (ORADE) occurred were associated with a mean difference of $4707 more compared to surgical procedures without ORADEs. Length of stay associated with a surgical ORADE was 3.4 days longer than procedures without ORADEs.6

Multi-modal analgesia (MMA), the combination of two or more analgesics to attack pain from different pathways in the body, may offer patients effective pain management while minimizing opioid monotherapy. The Joint Commission recommends MMA as a strategy to help avoid accidental opioid overuse7 and numerous professional organizations such as the American Society of Anesthesiologists, American Society for Pain Management Nursing, the American Geriatrics Society and Society for Critical Care Medicine, consider MMA a best practice.

Despite medical community support for MMA, some formularies rely on generic opioids instead, because they are so inexpensive. To achieve the best outcomes for our patients, we need to pause, carefully assess individual patient needs, and prescribe the proper course of care at the appropriate time for each patient. We also must have the ability to prescribe what we think is the best approach for each patient.

Access to and safe use of opioids and alternative options

Opioids, when prescribed, have an important place in pain management, and ensuring their safe use is critical for individuals and society. But first, appropriate patients must have access, including those diagnosed with chronic pain. Patients also must have access to other management options, such as physical therapy and rehabilitation, psychological counseling, transcutaneous electrical nerve stimulation, and complementary approaches including acupuncture, therapeutic yoga, and biofeedback. It is critical that we discuss these options and ensure their availability to individuals in need.

Today, the pendulum seems to have swung too far on the side of caution in an attempt to reign in pain medication use. Although it is true in some cases that overreliance on opioids alone to manage pain has led to unanticipated, costly complications (including societal challenges related to misuse, abuse, and diversion), in other cases, those who truly need certain medicines or services find themselves with limited or no access because of stigma and safeguards aimed at unsavory “patients” (and unfortunately some clinicians). Sadly, for every doctor-shopping abuser, there are an untold number of patients suffering with debilitating pain caused by a serious disease or treatment consequence, traumatic injury, or major surgery. Take for example patients who experience HIV treatment-related neuropathy, postmastectomy-related pain, or chemotherapy-related neuropathy; many of these conditions require opioids or other medications.

For patients who are appropriately prescribed prescription pain medications, responsible use, storage, and disposal can help protect individuals, their families, and communities from harm.  This is where prescribers can play a vital role.

When prescribing certain pain medications, there must also be proactive discussion with patients that leads to a commitment to safely use, store and dispose of such medications, as part of the pain management plan. Prescribers also should be mindful to take appropriate steps to screen for potential abuse.  The Alliance for Balanced Pain Management offers tips for the safe use, storage and disposal of pain medication. 

Although pain relief is a national issue, we cannot forget the individual patient. As clinicians, our goal is not just to relieve pain, but to get patients functional and back to doing the things they normally do as safely and efficiently as possible. As such, we have a moral obligation that our patients have access to all available resources to alleviate their pain. 

Being on the “CVS TEAM” takes more than just a good education ?

triathalonArchitecture-Graphic-Standard

 

 

 

 

 

 

 

 

CA Pharmacy Manager

http://m.jobs.cvshealth.com/california/pharmacist-retail-store/jobid9088293-ca-pharmacy-manager-jobs/description/true

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. If you require assistance to apply for this job, please contact us by clicking AA EEO CVS Health

Read the PHYSICAL REQUIREMENTS for being a CVS PIC. Does it sound like there could be any “accommodations” for anyone ? As I remember the employment laws, a company can’t ask an certain questions about a applicant before they are offered/accepted a job. Of course, if a applicant voluntarily divulges some “private information” before the job is offered.. like you will need some accommodations.. it can be used against the applicant in the hiring process. Of course, by clicking on the click within the job ad.. that you have a disability… chances of being hired because of the required accommodations are probably between SLIM and NONE !

Being on the “CVS TEAM” seems to be similar to getting on just about any team that require a high degree of physical abilities.  Maybe the Pharmacy schools need to reevaluate their protocol of who they accept… to include certain physical attributes and/or capabilities.

Location: Thousand Oaks, CA
Job Category: Pharmacist – Retail Store
Clinical Licensure Required : Pharmacist
Job Type: Full Time

Position Summary:

Health is everything. At CVS Health we are committed to increasing access, lowering costs and improving quality of care. Millions of times a day, we’re helping people on their path to better health—from advising on prescriptions to helping manage chronic and specialty conditions. Because we’re present in so many moments, big and small, we have an active, supportive role in shaping the future of health care. The Pharmacy Manager plays one of the most important roles at CVS Health as our pharmacy teams are at the forefront of this mission and are critical in both shaping healthcare and helping people on their path to better health.

The Pharmacy Manager leads and directs the Pharmacy Staff (comprised of both staff Pharmacists and pharmacy technicians) who help customers on their path to better health. The Pharmacy Manager is accountable for management, oversight and operation of all aspects of the pharmacy within his/her store including pharmacy professional practice, regulatory requirements, quality assurance, customer service, personnel management, inventory management, financial profitability and loss prevention. A key component of the Pharmacy Manager role is keeping customers and patients healthy through adoption and management of our patient care programs. Pharmacy Managers are also responsible for the development and performance management of all Pharmacy Staff, identification of critical business opportunities, establishing meaningful solutions to drive performance and growth and successfully implementing those plans by managing the Pharmacy Staff to accomplish these goals.

PHYSICAL ESSENTIAL FUNCTIONS OF THE JOB
• Constant standing: remaining upright on the feet, particularly for sustained periods of time.
• Occasional walking: moving about on foot to accomplish tasks, particularly for moving from one work area to another
• Frequent handling, fingering and/or feeling: Picking, pinching, typing or otherwise working primarily with fingers rather than whole hand or arm.
• Occasional reaching: extending hand(s) and arm(s) in any direction
• Occasional stooping: bending body downward and forward by bending spine at the waist
• Occasional bending: stooping to a considerable degree and requiring full use of the lower extremities and back muscles
• Occasional talking: expressing or exchanging ideas by means of spoken word; those activities where detailed or important spoken instructions must be conveyed accurately
• Occasional hearing: perceiving the nature of sounds at normal speaking levels with or without correction, and having the ability to receive detailed information through oral communication
• Visual Acuity:
The worker is required to have close visual acuity to perform activities such as: transcribing, viewing a computer terminal, reading, visual inspection involving small parts.
• Occasional lifting of up to 30 lbs
• Light work: Exerting up to 30 lbs of force occasionally and/or up to 10 lbs of force frequently, and/or a negligible amount of force constantly to move objects

Required Qualifications:

• Active Pharmacy License in the state in which he/she is employed
• Not on the DEA Excluded Parties List
• Immunization Certification through an accredited organization (i.e. APhA)*
• Listed on the pharmacy state license as the ‘pharmacist in charge’
• Submission of required information/documents to your state PMP administrator to register for PMP access (in states with active PMP for pharmacist use).

Education:

Bachelor of Science in Pharmacy or Pharm. D. degree

Business Overview:

CVS Health, through our unmatched breadth of service offerings, is transforming the delivery of health care services in the U.S. We are an innovative, fast-growing company guided by values that focus on teamwork, integrity and respect for our colleagues and customers. What are we looking for in our colleagues? We seek fresh ideas, new perspectives, a diversity of experiences, and a dedication to service that will help us better meet the needs of the many people and businesses that rely on us each day. As the nation’s largest pharmacy health care provider, we offer a wide range of exciting and fulfilling career opportunities across our three business units – MinuteClinic, pharmacy benefit management (PBM) and retail pharmacy. Our energetic and service-oriented colleagues work hard every day to make a positive difference in the lives of our customers.

CVS Health is an equal opportunity employer. We do not discriminate in hiring or employment against any individual on the basis of race, color, gender, national origin, ancestry, religion, physical or mental disability, age, veteran status, sexual orientation, gender identity or expression, marital status, pregnancy, citizenship, or any other factor protected by anti-discrimination laws. Furthermore, we comply with the laws and regulations set forth in the following EEO is the Law Poster: EEO IS THE LAW EEO IS THE LAW POSTER GINA SUPPLEMENT

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. If you require assistance to apply for this job, please contact us by clicking AA EEO CVS Health

For inquiries related to the application process or technical issues please contact the Kenexa Helpdesk at 1-855-338-5609. For technical issues with the Virtual Job Tryout assessment, contact the Shaker Help Desk at 1-877-987-5352. Please note that we only accept resumes via our corporate website: http://www.cvshealth.com/careers

Never underestimate the power of stupid people in large group

congressstupidSenator proposing to charge drug companies for unused pills

http://wwlp.com/2015/12/03/senator-proposing-to-charge-drug-companies-for-unused-pills/

STATE HOUSE, BOSTON, DEC. 3, 2015…..The state would be able to bill pharmaceutical companies for unused drugs turned in by patients and put the proceeds toward addiction treatment and recovery programs, under a bill now before lawmakers.

The bill’s sponsor, Sen. Daniel Wolf, told the Joint Committee on Public Health Thursday that his legislation would require a new degree of responsibility and accountability from drug companies as the state grapples with rising rates of overdose and addiction.

“There’s no intent, from my perspective, that the pharmaceutical companies are intentionally creating addiction,” said Wolf, a Harwich Democrat. “I wouldn’t go that far. But I think one of the solutions we haven’t talked nearly enough about in this building is what role the pharmaceutical companies can play and should play in preventing and treating the problems that their drugs are really a very important part of creating.”

Wolf’s bill would expand upon existing drug take-back centers voluntarily set up in some communities, often at police stations, by calling upon the Department of Public Health to establish collection and disposal sites that could be easily accessed from all regions of the state.

The collection points would include technology to identify and catalog each pill before they were destroyed. That information could then be used to prepare an invoice that would be sent to the drug’s manufacturer. Money received through the buyback program would be deposited in a dedicated fund for substance abuse services.

“We know that we are falling way short in the ability to pay for these programs, and this would create a revenue stream,” Wolf said.

A substance-abuse prevention bill passed by the Senate in October (S 2020) contains a provision similar to Wolf’s program, calling for drug manufacturers to operate or participate in a collection and disposal program.

A national trade group representing pharmaceutical companies opposes Wolf’s bill, arguing that drug collection sites could potentially create new venues for drug misuse by establishing one public location where pills are aggregated and could be stolen.

“They would be known sites in the community where people could go to access drugs,” said Leslie Wood, deputy vice president of Pharmaceutical Research and Manufacturers of America. “We don’t believe it’s secure.”

Wood’s organization, known as PhRMA, does not object to drug disposal sites run by law enforcement agencies, she said.

In general, Wood said, PhRMA would prefer to see patients throw out unused medications with their regular trash, because they can get rid of them immediately instead of making a special trip or waiting for a dedicated take-back day.

“We don’t want patients to hold on to their unused medicines,” she said. “We want them to take them as they’re prescribed, secure them in your house, know what you have in your house, and when you don’t need them anymore dispose of them in your household trash.”

Of various proposals raised recently to combat opioid abuse, several have targeted the issue of unwanted medication that could be subject to misuse.

The Senate’s opioid bill also includes a measure allowing patients to request that a pharmacist only partially fill a prescription for certain drugs, while a bill filed by Gov. Charlie Baker would limit the supply of opioids doctors could initially prescribe a patient.

Elected officials have also voiced support for an initiative led by the Safe Homes Coalition, a California-based nonprofit, encouraging homeowners to safeguard and hide their prescription drugs before welcoming visitors for events like real estate open houses.

Exploring the impact of external expertise in pharmaceuticals, it’s evident that partnerships can greatly enhance efficiency. For more details, visit https://www.proteros.com/ to see how their services can integrate seamlessly into your development strategy, thus optimizing the pathway from laboratory research to market.

 

Copyright 2015 State House News Service